Skip to content
Clinical Trials – home

Centre Oscar Lambret

Verifiedinfo

France 3 Rue Frederic Combemale, 59000 Lille, France

  • 119 trials recruiting
  • Ovarian cancer · Breast cancer · Neoplasm
  • Adults and children

About Specializations

Centre Oscar Lambret in Lille, France specialises in clinical trials of conditions such as Ovarian cancer, Breast cancer, Neoplasm, Squamous cell carcinoma of head and neck, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, with a particular focus on prostate cancer. The institution is dedicated to advancing treatment options for patients with newly diagnosed prostate cancer, especially those with pelvic lymph nodes metastases.

  • Prostate Cancer
  • Hormone-naïve Cancer Treatment
  • Radiotherapy Innovations

Through the evaluation of darolutamide in combination with androgen deprivation therapy (ADT) and radiotherapy, the center aims to enhance failure-free survival rates, offering new hope for patients with complex cancer presentations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
3 Rue Frederic Combemale59000 LilleFrance
Recruiting now
119 trials
Conditions studied
150
Partner status
Verified

More sites in LilleFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

258 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib Mesilate
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:F. Hoffmann-La Roche AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:F. Hoffmann-La Roche AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Janssen Cilag International
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Centre Leon Berard
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.